Targeting intracranial patient-derived glioblastoma (GBM) with a NIR-I fluorescent immunoconjugate for facilitating its image-guided resection RSC ADVANCES Hettie, K. S., Teraphongphom, N., Ertsey, R. D., Rosenthal, E. L., Chin, F. T. 2020; 10 (69): 42413–22

View details for DOI 10.1039/d0ra07245a

View details for Web of Science ID 000592897600049